Current evidence linking microbiota-associated metabolic networks to renal immune remodeling across different kidney diseases is summarized, highlighting metabolite origin, shared target-cell responses, disease-specific and context-dependent mechanisms, and current evidence limitations.
Hong-Kun Zhang, Tao Zhang, Zheng-Chao Pan et al.· Frontiers in Microbiology· 0 citations
ABSTRACT Objective: To evaluate the clinical efficacy of combining cardiovascular agents with statins in the treatment of coronary heart disease(CHD). Methodology: This was a retrospective study. A total of 110 patients diagnosed with CHD and treated at Shijiazhuang Eighth Hospital between January 2024 to December 2025...
Zhi-Li Chen, Qian-Qian Zhang, Yue Zhang et al.· Pakistan Journal of Medical...· 0 citations
It is demonstrated that combining clinical, plaque, and radiomic features significantly improves MACE prediction in CAD, and that radiomics offers substantial incremental prognostic value, providing a reliable non-invasive risk stratification tool.
Yue Zhang, Hong-Kun Zhang, Ming-Lang Yang et al.· Frontiers in Cardiovascular...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.